507 results on '"Gong, Yanqing"'
Search Results
2. Preliminary Study of Whole-Genome Bisulfite Sequencing and Transcriptome Sequencing in VHL Disease-Associated ccRCC
3. Correction: Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2
4. Deep-profiling of phospholipidome via rapid orthogonal separations and isomer-resolved mass spectrometry
5. TRAF2 promotes M2-polarized tumor-associated macrophage infiltration, angiogenesis and cancer progression by inhibiting autophagy in clear cell renal cell carcinoma
6. Correction: Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA
7. Metabolomic landscape of renal cell carcinoma in von Hippel-Lindau syndrome in a Chinese cohort
8. VHL mutation drives human clear cell renal cell carcinoma progression through PI3K/AKT-dependent cholesteryl ester accumulation
9. PD16-07 MOLECULAR MECHANISMS OF CLDN10-ATP5O REGULATION OF MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION TO INHIBIT RENAL CELL CARCINOMA METASTASIS
10. PD48-06 URINE CELLULAR DNA METHYLATION AND MUTATION TEST FOR DETECTING UROTHELIAL CARCINOMA
11. MP65-13 MECHANISM OF RBM15-MEDIATED ZO2 mRNA N6-METHYLADENOSINE METHYLATION MODIFICATION REGULATING MALIGNANT PROGRESSION OF BLADDER CANCER
12. Correction to: Let‑7d inhibits intratumoral macrophage M2 polarization and subsequent tumor angiogenesis by targeting IL‑13 and IL‑10
13. PHGDH-mediated endothelial metabolism drives glioblastoma resistance to chimeric antigen receptor T cell immunotherapy
14. Cytoskeleton regulator RNA expression on cancer-associated fibroblasts is associated with prognosis and immunotherapy response in bladder cancer
15. ZNF582 overexpression restrains the progression of clear cell renal cell carcinoma by enhancing the binding of TJP2 and ERK2 and inhibiting ERK2 phosphorylation
16. Correction for: MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition
17. Protocol to generate traceable CAR T cells for syngeneic mouse cancer models
18. An immunosuppressive vascular niche drives macrophage polarization and immunotherapy resistance in glioblastoma
19. Construction and validation of a ferroptosis-related long noncoding RNA signature in clear cell renal cell carcinoma
20. Endothelial plasticity drives aberrant vascularization and impedes cardiac repair after myocardial infarction
21. MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T
22. Prediction of pathological staging and grading of renal clear cell carcinoma based on deep learning algorithms
23. Association between vasectomy and risk of prostate cancer: a meta-analysis
24. Noninvasive evaluation of tumor immune microenvironment in patients with clear cell renal cell carcinoma using metabolic parameter from preoperative 2-[18F]FDG PET/CT
25. Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α.
26. The role of clinical pharmacist in the clinical pathway of acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
27. Emergence of local collective action for land adjustment in land consolidation in China: An archetype analysis
28. Let-7d inhibits intratumoral macrophage M2 polarization and subsequent tumor angiogenesis by targeting IL-13 and IL-10
29. Stereotactic radiosurgery for central nervous system hemangioblastoma in von Hippel-Lindau disease: A systematic review and meta-analysis
30. Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastoma
31. Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40
32. Correction to: Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1
33. Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1
34. Preoperative PI-RADS Version 2 scores helps improve accuracy of clinical nomograms for predicting pelvic lymph node metastasis at radical prostatectomy
35. Identification of plasma secreted phosphoprotein 1 as a novel biomarker for upper tract urothelial carcinomas
36. Multitasking Pharmacophores Support Cabotegravir-Based Long-Acting HIV Pre-Exposure Prophylaxis (PrEP).
37. Construction of a two-gene prognostic model related to ferroptosis in renal cell carcinoma
38. Cell-cycle arrest and senescence in TP53-wild type renal carcinoma by enhancer RNA-P53-bound enhancer regions 2 (p53BER2) in a p53-dependent pathway
39. Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2
40. Experimental Research on Vibration Dynamics Performance of Type B Metro Vehicles
41. Determination of Whether Apex or Non-Apex Prostate Cancer Is the Best Candidate for the Use of Prostate-Specific Antigen Density to Predict Pathological Grade Group Upgrading and Upstaging after Radical Prostatectomy
42. Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy
43. Selective and Reliable Electrochemical Sensor Based on Polythionine/AuNPs Composites for Epinephrine Detection in Serum
44. Correction: Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma
45. A cost-effective diagnostic approach of urothelial carcinomas in 2 mL full voided urine based on novel panels of dual methylated DNA markers
46. VHL Mutation Drives Human Clear Cell Renal Cell Carcinoma Progression Through PI3K/AKT-Dependent Cholesteryl Ester Accumulation
47. Multiparametric Magnetic Resonance Imaging-based Prostate Specific Antigen Density and PI-RADSv2 score help identify Apical Prostate Cancer
48. A Novel Cuproptosis-Related Prognostic Model and the Hub Gene FDX1 Predict the Prognosis and Correlate with Immune Infiltration in Clear Cell Renal Cell Carcinoma
49. Initial characterization of immune microenvironment in pheochromocytoma and paraganglioma
50. Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.